Researchers have found that the investigational drug selumetinib shuts down the signaling of genetic mutations that prevent some patients' thyroid cancer tumors from absorbing radioiodine, the most effective treatment for the disease.
..
.
Drug shown to reverse radioiodine resistance in some advanced thyroid cancers
Researchers have found that the investigational drug selumetinib shuts down the signaling of genetic mutations that prevent some patients' thyroid cancer tumors from absorbing radioiodine, the most effective treatment for the disease.
There are currently 1 users browsing this thread. (0 members and 1 guests)
Posting Permissions
Quote